HFpEF remains a challenging clinical syndrome to even define, let alone treat. This session will review how to define HFpEF for clinical practice and study design, how to integrate current diagnostic tools optimally, and how to apply existing and new technologies to advanced phenotyping of HFpEF.
Review the clinical and physiologic information provided by currently available diagnostic techniques in the evaluation of HFpEF.
Assess the indications for techniques in the clinical evaluation of patients with HFPEF.
Recognize the potential of these techniques for the assessment of drug effects in clinical trials.
MD, MTR, FHFSA, FACC,
Assistant Professor of Medicine,
University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
Professor of Medicine; Chief, Division of Cardiovascular Medicine; Executive Director, Cardiovascular Service Line,
University of Utah
Department of Medicine, Division of Cardiology,
University of Texas Southwestern Medical Center
M. Shah ,
MD, MPH, ,
Assistant Professor of Medicine - Harvard Medical School,
Brigham and Women's Hospital